Civic AI
Procurement intelligence
Federal contract award
OSIVAX - CLINICAL PROOF OF CONCEPT OF OVX836, A SINGLE-SHOT BROADLY PROTECTIVE INFLUENZA A VACCINE FOR IMMEDIATE PROTECTION AGAINST EMERGING PANDEMIC STRAINS
OSIVAX · Department of Health and Human Services
- Value
- $19,485,392
- Start
- Jul 25, 2025
- End
- Jul 24, 2028
- Action date
- May 19, 2026
- PIID
- 75A50125C00008
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- —
- Award type
- DEFINITIVE CONTRACT
Description
OSIVAX - CLINICAL PROOF OF CONCEPT OF OVX836, A SINGLE-SHOT BROADLY PROTECTIVE INFLUENZA A VACCINE FOR IMMEDIATE PROTECTION AGAINST EMERGING PANDEMIC STRAINS
Need modifications, related awards, and vendor peers? Open the full award workspace.